
Opinion|Videos|November 8, 2024
Impact of Treatment Delays on Patient Outcomes
Author(s)Toby Maher, MD, PhD
Key Takeaways
- Timely intervention in oncology is critical for improving survival rates, disease progression, and quality of life.
- Delays in treatment can result in advanced disease stages, reduced treatment efficacy, and increased morbidity.
Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How does a delay in treatment affect patient outcomes and disease progression?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5












